Clinical Trials · NCT04026256
Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Massachusetts General Hospital
- Enrollment
- 37
- Start date
- Sep 2019
- Locations
- 1 site, United States
- Primary endpoint
- Cancellous Bone Formation Rate at Month 3